News
JERSEY CITY, NJ, USA I July 7, 2025 I Celltrion USA today announced that STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo), biosimilars referencing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback